100 related articles for article (PubMed ID: 23236681)
21. The impact of oral contraceptives and metformin on anti-Müllerian hormone serum levels in women with polycystic ovary syndrome and biochemical hyperandrogenemia.
Panidis D; Georgopoulos NA; Piouka A; Katsikis I; Saltamavros AD; Decavalas G; Diamanti-Kandarakis E
Gynecol Endocrinol; 2011 Aug; 27(8):587-92. PubMed ID: 20836726
[TBL] [Abstract][Full Text] [Related]
22. Quality of life issues. Potential role for an oral contraceptive containing ethinyl estradiol and drospirenone.
Dickerson V
J Reprod Med; 2002 Nov; 47(11 Suppl):985-93. PubMed ID: 12497673
[TBL] [Abstract][Full Text] [Related]
23. Evolution of progestins. Focus on the novel progestin drospirenone.
Thorneycroft IH
J Reprod Med; 2002 Nov; 47(11 Suppl):975-80. PubMed ID: 12497671
[TBL] [Abstract][Full Text] [Related]
24. [Novynette--trends in contraception at the beginning of the new millennium].
Ivanov S; Sigridov I
Akush Ginekol (Sofiia); 2004; 43 Suppl 2():30-2. PubMed ID: 15518273
[No Abstract] [Full Text] [Related]
25. A historical cycle control comparison of two drospirenone-containing combined oral contraceptives: ethinylestradiol 30 μg/drospirenone 3 mg administered in a 21/7 regimen versus ethinylestradiol 20 μg/drospirenone 3 mg administered in a 24/4 regimen.
Marr J; Gerlinger C; Kunz M
Eur J Obstet Gynecol Reprod Biol; 2012 May; 162(1):91-5. PubMed ID: 22391750
[TBL] [Abstract][Full Text] [Related]
26. Femodene/Minulet--how different is gestodene?
Drug Ther Bull; 1990 May; 28(11):41-2. PubMed ID: 2131208
[No Abstract] [Full Text] [Related]
27. [Back up contraception].
Dacheva T
Akush Ginekol (Sofiia); 2008; 47 Suppl 2():28-31. PubMed ID: 19504704
[No Abstract] [Full Text] [Related]
28. [Escapelle - a method of choice for emergency contraception ].
Tanchev L
Akush Ginekol (Sofiia); 2008; 47 Suppl 2():24-7. PubMed ID: 19496450
[No Abstract] [Full Text] [Related]
29. Confluent and reticulated papillomatosis associated with polycystic ovary syndrome treated with a combined contraceptive containing drospirenone.
Ozdemir S; Ozdemir M; Toy H
J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):358-9. PubMed ID: 18540980
[No Abstract] [Full Text] [Related]
30. [Therapeutic trend in acne associated with the menstrual cycle].
Cersosimo L; Iannucci D; Consalvo F; Orgiu G
Clin Ter; 1983 Jun; 105(5):411-4. PubMed ID: 6223780
[No Abstract] [Full Text] [Related]
31. Estradiol in hormonal contraception: real evolution or just same old wine in a new bottle?
Grandi G; Facchinetti F; Bitzer J
Eur J Contracept Reprod Health Care; 2017 Aug; 22(4):245-246. PubMed ID: 28902531
[No Abstract] [Full Text] [Related]
32. [The position of drospirenone in premenstrual syndrome teratment].
Havlín M
Ceska Gynekol; 2006 Jan; 71(1):70, 72-3. PubMed ID: 16465920
[TBL] [Abstract][Full Text] [Related]
33. A new hormone therapy with drospirenone and NO production in postmenopausal women.
Tsuda K
Hypertension; 2006 Nov; 48(5):e106; author reply e107. PubMed ID: 17000926
[No Abstract] [Full Text] [Related]
34. A prospective randomized trial comparing low-dose ethinyl estradiol and drospirenone 24/4 combined oral contraceptive vs. ethinyl estradiol and drospirenone 21/7 combined oral contraceptive in the treatment of hirsutism.
Oner G; Muderris II
Contraception; 2011 Nov; 84(5):508-11. PubMed ID: 22018126
[TBL] [Abstract][Full Text] [Related]
35. [Reduced estrogen ovulation inhibitor in acne therapy. Double-blind study comparing Diane-35 to Diane].
Aydinlik S; Lachnit-Fixson U; Lehnert J
Fortschr Med; 1986 Jul; 104(27-28):547-50. PubMed ID: 2943651
[No Abstract] [Full Text] [Related]
36. Consumption of combined oral contraceptives and venous thromboembolism in Zagreb, Croatia.
Leppée M; Culig J; Eric M
Eur J Contracept Reprod Health Care; 2010 Dec; 15(6):445-6. PubMed ID: 21091178
[No Abstract] [Full Text] [Related]
37. [Extracontraceptive benefits of EE/DRSP (Yaz) in 24+4 day regimen].
Bruni Bresciani V
Minerva Ginecol; 2010 Jun; 62(3):261-6. PubMed ID: 20595950
[TBL] [Abstract][Full Text] [Related]
38. Oral contraceptives and coronary artery atherosclerosis of cynomolgus monkeys.
Clarkson TB; Shively CA; Morgan TM; Koritnik DR; Adams MR; Kaplan JR
Obstet Gynecol; 1990 Feb; 75(2):217-22. PubMed ID: 2300348
[TBL] [Abstract][Full Text] [Related]
39. [Clinical study of the low dose oral contraceptive novynette].
Uchikova E; Milchev N
Akush Ginekol (Sofiia); 2003; 42(4):15-6. PubMed ID: 14577362
[TBL] [Abstract][Full Text] [Related]
40. [The latest progestagens].
Belaïsch J; Eliakim V
Contracept Fertil Sex; 1993 Apr; 21(4):287-93. PubMed ID: 7951628
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
